Valuation: UCB

Market Cap 41.53B 48.41B 38.78B 35.58B 66.9B 4,627B 68B 458B 179B 2,321B 182B 178B 7,673B P/E 2026 *
21.8x
P/E 2027 * 17.9x
Enterprise Value 41.85B 48.78B 39.08B 35.85B 67.42B 4,663B 68.53B 461B 181B 2,339B 183B 179B 7,732B EV / Sales 2026 *
4.82x
EV / Sales 2027 * 4.1x
Free-Float
61.59%
Yield 2026 *
0.67%
Yield 2027 * 0.69%
1 day+0.23%
1 week-1.80%
Current month-2.29%
1 month-8.98%
3 months-7.28%
6 months-23.09%
Current year-8.72%
1 week 211.6
Extreme 211.6
220.8
1 month 211.6
Extreme 211.6
251.5
Current year 211.6
Extreme 211.6
289.5
1 year 191.2
Extreme 191.2
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 60 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.23%-1.80%+13.14%+170.56% 47.97B
+3.78%+5.37%+47.06%+3.50% 80.91B
+4.23%+26.48%-21.21%-34.82% 53.62B
+0.85%-0.32%-1.93%+30.25% 50.13B
+4.24%+6.08%+59.56%-15.16% 31.41B
+176.97%+173.88%+524.79%+71.60% 25.14B
+4.05%+6.38%+50.33%+100.61% 25.03B
+4.73%+8.88%+9.46%+232.58% 21.45B
+0.22%+4.68%+66.64%+127.79% 16.93B
+1.17%+0.13%+71.64%+192.31% 16.22B
Average +2.08%+21.02%+81.95%+87.92% 36.88B
Weighted average by Cap. +2.39%+16.07%+59.70%+60.27%

Financials

2026 *2027 *
Net sales 8.69B 10.13B 8.11B 7.44B 14B 968B 14.23B 95.73B 37.48B 486B 38.03B 37.2B 1,605B 9.69B 11.3B 9.05B 8.3B 15.61B 1,080B 15.87B 107B 41.81B 542B 42.42B 41.49B 1,790B
Net income 1.93B 2.24B 1.8B 1.65B 3.1B 215B 3.15B 21.21B 8.31B 108B 8.43B 8.24B 356B 2.33B 2.71B 2.17B 1.99B 3.75B 259B 3.81B 25.64B 10.04B 130B 10.19B 9.97B 430B
Net Debt 321M 374M 300M 275M 517M 35.79B 526M 3.54B 1.39B 17.95B 1.41B 1.38B 59.35B -1.8B -2.1B -1.68B -1.54B -2.9B -200B -2.95B -19.82B -7.76B -101B -7.87B -7.7B -332B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
26-08-19 €217.80 +0.23% 199,754
26-08-18 €217.30 +0.88% 164,194
26-08-17 €215.40 +1.46% 250,813
26-08-14 €212.30 -3.10% 199,251
26-08-13 €219.10 -1.22% 216,220
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
217.80EUR
Average target price
285.26EUR
Spread / Average Target
+30.97%

Quarterly revenue - Rate of surprise